Office of the Director, National Institutes of Health; Notice of Closed Meeting

---
identifier: "/us/fr/05-17016"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Office of the Director, National Institutes of Health; Notice of Closed Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "05-17016"
section_name: "Office of the Director, National Institutes of Health; Notice of Closed Meeting"
positive_law: false
currency: "2005-08-26"
last_updated: "2005-08-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "05-17016"
document_type: "notice"
publication_date: "2005-08-26"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "70 FR 50378"
fr_volume: 70
---


#  Office of the Director, National Institutes of Health; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Advisory Committee to the Director, NIH.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* Advisory Committee to the Director, NIH.

*Date:* September 6, 2005.

*Time:* 11 a.m. to 12 p.m.

*Place:* National Institutes of Health, Building 31, 31 Center Drive, Room 5B64, Bethesda, MD 20892.

*Agenda:* To review and evaluate grant applications (Telephone Conference Call).

*Contact Person:* Shelly Pollard, ACD Coordinator, National Institutes of Health, 9000 Rockville Pike, Building 31, Room 5B64, Bethesda, MD 20892, 301-496-0959.

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

Dated: August 19, 2005.

Anthony M. Coelho, Jr.,

Acting Director, Office of Federal Advisory Committee Policy.